PD-1 and PD-L1 antibodies in cancer: current status and future directions Arjun Vasant BalarJeffrey S. Weber Review 17 February 2017 Pages: 551 - 564
Differences in the frequencies of HLA-class I and II alleles between German patients with renal cell carcinoma and healthy controls Steffen GoebelAstrid KehlenHelge Taubert Original Article 09 February 2017 Pages: 565 - 571
Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapy Laura LattanzioNerina DenaroMarco Merlano Original Article 14 February 2017 Pages: 573 - 579
Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis Viktoria BergqvistErik HertervigJan Marsal Original Article Open access 15 February 2017 Pages: 581 - 592
Tumor specific regulatory T cells in the bone marrow of breast cancer patients selectively upregulate the emigration receptor S1P1 Anchana RathinasamyChristoph DomschkePhilipp Beckhove Original Article Open access 21 February 2017 Pages: 593 - 603
Upregulation of thioredoxin-1 in activated human NK cells confers increased tolerance to oxidative stress Kousaku MimuraLey-Fang KuaKoji Kono Original Article 21 February 2017 Pages: 605 - 613
FOXO3, estrogen receptor alpha, and androgen receptor impact tumor growth rate and infiltration of dendritic cell subsets differentially between male and female mice Matthew G. ThompsonDaniel S. PeifferStephanie K. Watkins Original Article 22 February 2017 Pages: 615 - 625
Expression of VISTA correlated with immunosuppression and synergized with CD8 to predict survival in human oral squamous cell carcinoma Lei WuWei-Wei DengZhi-Jun Sun Original Article 24 February 2017 Pages: 627 - 636
Interleukin 21 inhibits cancer-mediated FOXP3 induction in naïve human CD4 T cells Vinodh KannappanKate ButcherKesley Attridge Original Article Open access 27 February 2017 Pages: 637 - 645
Intralesional treatment of metastatic melanoma: a review of therapeutic options Benjamin WeideDario NeriGiuliano Elia Focussed Research Review 11 January 2017 Pages: 647 - 656
Evolution of MHC-based technologies used for detection of antigen-responsive T cells Amalie Kai BentzenSine Reker Hadrup Focussed Research Review Open access 17 March 2017 Pages: 657 - 666
Exercise and cancer: from “healthy” to “therapeutic”? Manja IdornPer thor Straten Focussed Research Review Open access 21 March 2017 Pages: 667 - 671
Mechanisms of efficacy in cancer immunotherapy: 14th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 10–12, 2016 Judith TheelenJennifer BraunMatthias Miller Meeting Report 01 March 2017 Pages: 673 - 681